Clinical Trial Update: Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether 17-alpha-hydroxyprogesterone caproate can prevent preterm birth in twin pregnancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• 17-alpha-hydroxyprogesterone caproate (17-alpha-hydroxyprogesterone caproate)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Preterm Delivery | Phase 2 | Status: COMPLETED